[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 25, Issue 3 (Spring 2021) ::
3 2021, 25(3): 244-253 Back to browse issues page
Phosphodiesterase Inhibitors and Eye
Abstract:   (720 Views)
Nowadays, Phosphodiesterase inhibitors (such as Sildenafil, Tadalafil, Vardenafil, and Avanafil) are used to treat erectile dysfunction in men and pulmonary arterial hypertension. There have been numerous reported ocular side effects of these drugs including anterior ischemic neuropathy, central serous chorioretinopathy, retinal hemorrhage, retinal vein occlusion, and retinal artery occlusion. Also, after taking phosphodiesterase inhibitors, various subjective vision complaints, such as Cyanopsia, blurred vision, diplopia, and photopsia are expressed by patients. We extensively searched phosphodiesterase inhibitors ocular side effects in the literature, using PubMed and Medline. In this review article, we classified the ocular side effects of these drugs and the controversies in the reports, the mechanism of action, paraclinical findings, as well as animal studies in this field.
 
Keywords: Nonarteritic Anterior Ischemic, Phosphodiesterase Inhibitors, Sildenafil, Tadalafil
Full-Text [PDF 385 kb]   (126 Downloads)    
Type of Study: Review | Subject: Ophthalmology
Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Phosphodiesterase Inhibitors and Eye. 3. 2021; 25 (3) :244-253
URL: http://binajournal.org/article-1-1092-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 25, Issue 3 (Spring 2021) Back to browse issues page
مجله چشم‌پزشکی بینا Bina Journal of Ophthalmology
Persian site map - English site map - Created in 0.04 seconds with 30 queries by YEKTAWEB 4355